Joint tissue study aims to personalize rare disease treatment
NCT ID NCT07503821
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether analyzing synovial tissue can help doctors better manage pigmented villonodular synovitis (PVNS), a rare joint disease that causes pain and joint damage. Researchers will collect tissue samples from 30 patients through biopsy or surgery to assess quality and patient acceptance. The goal is to understand the disease better and see if tissue analysis can guide personalized treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better, personalized treatment plans for people with PVNS, potentially reducing pain and joint damage.
What could go wrong
This is a small, early-stage study focused on gathering information, not testing a treatment. It may not lead to immediate changes in patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYNOVITIS VILLONODULAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nantes
Nantes, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospices Civils de Lyon
Lyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Cochin APHP
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact